Opus Genetics Inc
IRD
NASDAQ
Biotechnology
$3.61
USD
-0.11 (-2.96%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $309.49M
Volume 414.2K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SION | Sionna Therapeutics Inc | $2.31B | - | - | - | |
TLSI | TriSalus Life Sciences Inc | $351.59M | - | +39.6% | - | |
IMRX | Immuneering Corp | $336.43M | - | - | - | |
IRD | Opus Genetics Inc | $309.49M | - | -12.2% | - | |
MYGN | Myriad Genetics Inc | $307.03M | - | -3.2% | - | |
VNDA | Vanda Pharmaceuticals Inc | $304.35M | - | +8.2% | - | |
AVXL | Anavex Life Sciences Corp | $300.34M | - | - | - | |
FATE | Fate Therapeutics Inc | $293.73M | - | -52.6% | - | |
ANIK | Anika Therapeutics Inc | $286.13M | - | -2.5% | - | |
CAMP | CAMP4 Therapeutics Corp | $219.13M | - | +5.6% | - |
Top Peer by Growth
TriSalus Life Sciences Inc
+39.6% YoY Revenue
Best 1-Year Return
Opus Genetics Inc
+238.2% Return